Cencora, Inc. reported an insider ownership change involving Silvana Battaglia, who acquired shares of the company’s common stock on June 30, 2026. The Form 4, filed July 7, 2026, describes the transaction as a purchase of Cencora common stock through the company’s Employee Stock Purchase Plan. The filing notes that the purchase was exempt under Rule 16b-3(c) and Rule 16b-3(d), provisions that generally cover certain transactions between an issuer and its officers or directors under approved employee benefit or compensation plans. This indicates the acquisition was made through Cencora’s internal employee stock purchase arrangement rather than being described as an ordinary discretionary open-market trade. The supplied filing text does not include the number of shares purchased, the purchase price, a transaction code, or Battaglia’s beneficial ownership total following the transaction. As a result, the filing confirms the occurrence and nature of the acquisition but does not provide enough detail in the excerpt to quantify the size or economic value of the purchase. The report was signed on Battaglia’s behalf by Elizabeth S. Campbell, attorney-in-fact, on July 7, 2026. The key takeaway is that Battaglia increased her exposure to Cencora common stock through an employee stock purchase plan transaction on June 30, 2026, with the transaction treated as exempt under insider trading short-swing profit rules applicable to certain issuer-plan transactions.
Stock detail
Cencora (COR) stock price, chart, and key data
View Cencora stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Cencora
COR · XNYS
-$15.21 (-5.04%) past day
$286.50
Pre-market $286.13 (-0.13%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Dividend
Past Dividend Performance
$0.60
$0.60
$0.60
Annual Dividend Yield
0.84%
Dividend
$0.60 / Stock
Frequency
Quarterly Payment
Day range
$299.11 - $308.58
Close price
$300.71
Market cap
$59B
P/E ratio
34.11
About the company
Cencora Inc
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Kevin Hern
republican · House · OK-1
- —144 / 66 / 222
#2Jefferson Shreve
republican · House · IN-6
- —95 / 63 / 127
#3Ro Khanna
democrat · House · CA-17
- —65 / 8 / 123
#4Jared Moskowitz
democrat · House · FL-23
- —50 / 6 / 94
#5Rob Bresnahan
republican · House · PA-8
- —35 / 4 / 66
#6Gilbert Cisneros
democrat · House · CA-31
- —35 / 4 / 66
#7Kelly Morrison
democrat · House · MN-3
- —35 / 4 / 66
#8Donald J Trump
republican · Executive
- —27 / 3 / 52
#9Jared Moskowitz
democrat · House · FL-23
- —24 / 3 / 46
#10Greg Landsman
democrat · House · OH-1
- —26 / 12 / 40
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app